United States v. Sutter Health

District Court, N.D. California·Decided September 9, 2024·No. 4:14-cv-04100·Unknown

Opinion

UNITED STATES OF AMERICA, Case No. 14-cv-04100-KAW

Plaintiffs, ORDER GRANTING IN PART AND v. DENYING IN PART MOTIONS TO EXCLUDE RELATOR’S EXPERTS’ SUTTER HEALTH, et al., OPINIONS Defendants. Re: Dkt. Nos. 313, 314, 315

On September 10, 2014, Relator Laurie M. Hanvey filed the instant case against Defendants, asserting violations of the False Claims Act and California False Claims Act. (Compl., Dkt. No. 1.) On December 8, 2021, the operative complaint was filed against Defendants Sutter Health, Sutter Valley Hospitals, Sutter Valley Medical Foundation, and Sutter Bay Hospitals (collectively, “Sutter Health”), as well as Defendants Sutter Medical Group (“SMG”), East Bay Cardiac Surgery Center Medical Group (“East Bay Cardiac”), and Stephen K. Liu, M.D. Professional Corporation (“Liu PC”). (Third Amend. Compl. (“TAC”), Dkt. No. 175.) Pending before the Court is: (1) Sutter Health’s motion to exclude the opinions of Kathleen McNamara, (2) Sutter Health’s motion to exclude the opinions of Jerry Pratt, and (3) Sutter Health’s motion to exclude the opinions of Stanley J. Sokolove. Having considered the parties’ filings, the relevant legal authorities, and the arguments made at the August 28, 2024 hearing, the Court GRANTS IN PART and DENIES IN PART Defendants’ motions to exclude. The instant case concerns Sutter Health’s alleged scheme where it knowingly entered into compensation arrangements in violation of the Anti-Kickback Statute (“AKS”) and the Physician compensation, free employees, and other illegal incentives to the SMG, East Bay Cardiac, Liu PC, California Emergency Physicians Medical Group (“CEPMG”), and Sacramento Cardiovascular Surgeons Medical Group (“Sac Cardio”) (collectively, “Physician Groups”). (TAC at 3-4.) Relator further alleges that Defendant Sutter Health then knowingly submitted and/or caused others to submit false and fraudulent claims related to services rendered to patients referred to it by the Physician Groups, again in violation of the AKS and Stark Law. (TAC at 3-4.) On May 17, 2024, Defendants filed a joint motion for summary judgment. (Defs.’ MSJ, Dkt. No. 294.) Thereafter, Sutter Health filed the instant motions to exclude the testimony of Relator’s experts. (Mot. to Exclude McNamara, Dkt. No. 313; Mot. to Exclude Pratt, Dkt. No. 314; Mot. to Exclude Sokolove, Dkt. No. 315.) On July 15, 2024, Relator filed her oppositions to Sutter Health’s motions to exclude. (Opp’n re McNamara, Dkt. No. 328; Opp’n re Pratt, Dkt. No. 329; Opp’n re Sokolove, Dkt. No. 330.) On July 22, 2024, Sutter Health filed their replies in support of their motions to exclude. (Reply re Pratt, Dkt. No. 340; Reply re Sokolove, Dkt. No. 341; Reply re McNamara, Dkt. No. 342.) In determining whether expert testimony is admissible under Federal Rule of Evidence 702, the district court is charged with performing “a preliminary assessment of whether the reasoning or methodology underlying the testimony is scientifically valid and whether that reasoning or methodology properly can be applied to the facts in issue.” Daubert v. Merrell Dow Pharms., Inc., 509 U.S. 579, 592-93 (1993). This inquiry is “a flexible one,” and “[i]ts overarching subject is the scientific validity – and thus the evidentiary relevance and reliability – of the principles that underlie a proposed submission. The focus, of course, must be solely on principles and methodology, not on the conclusions that they generate.” Id. at 594-95. A. Motion to Exclude Kathleen McNamara Kathleen McNamara was retained by Relator to evaluate whether certain arrangements between Sutter Health and the Physician Groups were commercially reasonable and/or consistent forty years of experience in healthcare consulting, specializing in Medicare and Medicaid compliance, FMV examinations, commercial reasonableness reviews, and healthcare reimbursement. (Id. at 2.) Sutter Health challenges the following opinions. i. Sac Cardio Physician Assistant Services First, Ms. McNamara asserts that Sac Cardio was “double-dipping,” or double-billing by billing government payors for the physician assistant services that Sutter Health was already compensating Sac Cardio. (McNamara Report at 6, 15.) Sutter Health argues that this is an improper opinion because it is a finding of fact based on the record. (Mot. to Exclude McNamara at 7.) The Court agrees. Whether Sac Cardio was double-billing is a question of fact for a jury to determine based on the evidence, and Relator does not explain how Ms. McNamara’s specialized experience would be helpful in making this factual determination. At the hearing, Relator acknowledges that Ms. McNamara should not be testifying as to whether double billing occurred, and that she generally cannot weigh credibility or draw conclusions from the facts in the record. Thus, the Court will exclude this opinion. In excluding this opinion, however, the Court does not exclude Ms. McNamara’s opinion that double-billing (if it occurred) would be commercially unreasonable. Second, Ms. McNamara opines that Sutter Health was either aware or deliberately ignorant of Sac Cardio’s double-billing. (McNamara Report at 15.) Sutter Health contends this is an improper opinion about Sutter Health’s state of mind. (Mot. to Exclude McNamara at 8.) In general, “[e]xpert testimony as to intent, motive, or state of mind offers no more than the drawing of an inference from the facts of the case. The jury is sufficiently capable of drawing its own inferences regarding intent, motive, or state of mind from the evidence, and permitting expert testimony on this subject would be merely substituting the expert’s judgment for the jury’s and would not be helpful to the jury.” Siring v. Or. State Bd. of Higher Educ., 927 F. Supp. 2d 1069, 1077 (D. Or. 2013). As with Ms. McNamara’s opinion about Sac Cardio’s double-billing, Ms. McNamara’s opinion does not appear to be based on her experience, but on her interpretation of the factual evidence, namely a March 2011 e-mail exchange between Sac Cardio’s office manager this opinion. Third, Ms. McNamara opines that Sutter Health should have “verified one way or the other whether the groups were inappropriately billing for the services of the [mid-level practitioners].” (McNamara Report at 17.) While Sutter Health argues that Ms. McNamara did not provide a basis for this opinion, Mc. McNamara explained in her deposition that hospitals generally want to make sure they are not overcompensating physician groups in the form of stipends. (Mot. to Exclude McNamara at 10; McNamara Dep. at 124:4-6, Dkt. No. 313-4.) Given her experience in compliance and healthcare reimbursement, it is not apparent that this opinion would not be supported by her experience. The Court will not exclude this opinion. Finally, Ms. McNamara analyzes the physician assistant arrangement between Sutter Health and Sac Cardio, and concludes that Sac Cardio profited in some years from this arrangement. (McNamara Report at 15, Exh. A.) Sutter Health argues this opinion is neither relevant nor reliable because the Stark Law does not contain any requirement as to profitability. (Mot. to Exclude McNamara at 11.) Whether the Stark Law contains any requirements as to profitability is beside the point; the issue is whether the leasing arrangement overcompensated Sac Cardio, which Relator then argues makes the leasing arrangement commercially unreasonable and/or above the FMV. Sutter Health also argues that Ms. McNamara’s “analysis is based on factors like taxes and benefits that neither the group nor the hospital could assess in advance,” but does not explain how this makes her methodology unreliable. (Id.) Th

Free access — add to your briefcase to read the full text and ask questions with AI

United States v. Sutter Health, (N.D. Cal. 2024).

United States v. Sutter Health (United States v. Sutter Health) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
United States v. Adebola Adefunke Adebimpe
819 F.3d 1212 (Ninth Circuit, 2016)
United States v. Strange
23 F. App'x 715 (Ninth Circuit, 2001)